[1] RAMIREZ-ALARCON K,VICTORIANO M,MARDONES L,et al.Phytochemicals as potential epidrugs in type 2 diabetes mellitus[J].Front Endocrinol(Lausanne),2021,1(12):656-978.
[2] OGURTSOVA K,DA ROCHA FERNANDES J D,HUANG Y,et al.IDF diabetes atlas:global estimates for the prevalence of diabetes for 2015 and 2040[J].Diabetes Res Clin Pract,2017,128:4050.
[3] KIM E H,KIM H K,BAE S J,et al.Gender differences of visceral fat area for predicting incident type 2 diabetes in Koreans[J].Diabetes Res Clin Pract,2018,146:93-100.
[4] 安红红,徐静,马迎惠,等.2型糖尿病患者糖脂代谢、血清钙磷、骨代谢与骨密度的相关性研究[J].现代医学,2023,51(3):318-323.
[5] NADARAJAH C,FANANAPAZIR G,CUI E,et al.Association of pancreatic fat content with type II diabetes mellitus[J].Clin Radiol,2020,75(1):51-56.
[6] LI M,ZHENG Q,MILLER J D,et al.Aerobic training reduces pancreatic fat content and improves β-cell function:a randomized controlled trial using IDEAL-IQ magnetic resonance imaging[J].Diabetes Metab Res Rev,2022,38(4):e3516.
[7] 柴军,刘朋,洪旭,等.化学位移MRI对初诊2型糖尿病患者及健康人胰腺脂肪含量的比较研究[J].磁共振成像,2015,6(3):208-212.
[8] HEBER S D,HETTERICH H,LORBEER R,et al.Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes,diabetes,and controls from a general population without cardiovascular disease[J].PLoS One,2017,12(5):e0177154.
[9] 胡竞成,许虹,黄亚楠,等.胰腺脂肪含量与2型糖尿病的相关性[J].中华糖尿病杂志,2017,9(12):770-773.
[10] 黄小燕.采用IDEAL-IQ定量评估糖尿病患者腹部脂肪分布和内脏脂肪沉积[D].温州:温州医科大学,2018.
[11] 李元.胰腺、肝脏异位脂肪沉积IDEAL-IQ定量及MicroRNA-19a-3p与2型糖尿病的相关性研究[D].重庆:重庆医科大学,2018.
[12] STORZ C,ROSPLESZCZ S,LORBEER R,et al.Phenotypic multiorgan involvement of subclinical disease as quantified by magnetic resonance imaging in subjects with prediabetes,diabetes,and normal glucose tolerance[J].Invest Radiol,2018,53(6):357-364.
[13] 曾文彦,孙慧琳,庄娘妥,等.3.0T磁共振IDEAL-IQ技术量化评价2型糖尿病患者胰腺脂肪沉积及铁沉积的价值[J].国际医药卫生导报,2019,25(13):2027-2030.
[14] BORRA R,LAUTAMAKI R,PARKKOLA R,et al.Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus[J].Metabolism,2008,57(10):1445-1451.
[15] WANG M,LUO Y,CAI H,et al.Prediction of type 2 diabetes mellitus using noninvasive MRI quantitation of visceral abdominal adiposity tissue volume[J].Quant Imaging Med Surg,2019,9(6):1076-1086.
[16] SARMA M K,SAUCEDO A,DARWIN C H,et al.Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus[J].Magn Reson Imaging,2020,72:95-102.
[17] 段秀苹,雷燕,唐伟.胰腺内脂肪沉积与2型糖尿病相关性的MRI研究进展[J].中国中西医结合影像学杂志,2020,18(5):532-535.
[18] 朱红丽.2型糖尿病异位脂肪沉积与胰岛素抵抗、肌肉功能障碍相关性的磁共振研究[D].昆明:昆明医科大学,2022.
[19] ZHENG Y,YANG S,CHEN X,et al.The correlation between type 2 diabetes and fat fraction in liver and pancreas:a study using MR Dixon technique[J]. Contrast Media Mol Imaging,2022,2022:7073647.
[20] 王骏,郝金华,梁羡和.MRI定量分析肝、胰脂肪含量与糖耐量的相关性[J].国际医药卫生导报,2022,28(19):2740-2743.
[21] YI J,XU F,LI T,et al.Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus[J].Front Endocrinol(Lausanne),2023,14:1140111.
[22] KIEFER L S,FABIAN J,ROSPLESZCZ S,et al.Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes,prediabetes and healthy controls from the general population[J].Eur J Radiol,2018,105:261-268.
[23] FENG Y,YANG X,LI Y,et al.Metabolic score for visceral fat:a novel predictor for the risk of type 2 diabetes mellitus[J].Br J Nutr,2022,128(6):1029-1036.
[24] PAN L,XU Q,LIU J,et al.Dose-response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese[J].Front Endocrinol(Lausanne),2022,13:959860.
[25] TAYLOR R,Al-MRABEH A,SATTAR N.et al.Understanding the mechanisms of reversal of type 2 diabetes[J].Lancet Diabetes Endocrinol,2019,7(9):726-736.
[26] 江伟新,何丹丹,邱山虎,等.强度递增式运动干预对2型糖尿病患者体脂、血糖、血脂控制效果分析[J].现代医学,2023,51(4):535-540.
[27] HUANG S,LIANG Y,ZHONG X,et al.Pancreatic fat fraction in dual-energy computed tomography as a potential quantitative parameter in the detection of type 2 diabetes mellitus[J].Eur J Radiol,2023,159:110668.
[28] YU X,HUANG Y H,FENG Y Z,et al.Well-controlled versus poorly controlled diabetes in patients with obesity:differences in MRI-evaluated pancreatic fat content[J].Quant Imaging Med Surg,2023,13(6):3496-3507.
[29] WEN Y,CHEN C,KONG X,et al.Pancreatic fat infiltration,β-cell function and insulin resistance:a study of the young patients with obesity[J].Diabetes Res Clin Pract,2022,187:109860.
[30] KIM E H,KIM H K,LEE M J,et al.Sex differences of visceral fat area and visceral-to-subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus[J].Diabetes Metab J,2022,46(3):486-498.
[31] 彭晓勇,严俊,黄益龙,等.3D-IDEAL-IQ定量评估2型糖尿病患者肝脏和胰腺脂肪浸润及其与胰岛素抵抗的相关性[J].磁共振成像,2023,14(4):89-94.
[32] WAGNER R,ECKSTEIN S S,YAMAZAKI H,et al.Metabolic implications of pancreatic fat accumulation[J].Nat Rev Endocrinol,2022,18(1):43-54.
[33] YAMAZAKI H,TAUCHI S,MACHANN J,et al.Fat distribution patterns and future type 2 diabetes[J].Diabetes,2022,71(9):1937-1945.
[34] DEMIR S,NAWROTH P P,HERZIG S,et al.Emerging targets in type 2 diabetes and diabetic complications[J].Adv Sci(Weinh),2021,8(18):e2100275. |